Pacira reported $55.19M in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
Astellas Pharma JPY 94.83B 17.97B Jun/2025
Bristol-Myers Squibb USD 3.37B 339M Jun/2025
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
J&J USD 7.6B 304M Jun/2025
Ligand Pharmaceuticals USD 11.16M 6.32M Jun/2025
Novo Nordisk 12.85B 44M Jun/2025
Pacira USD 55.19M 20.88M Jun/2025
Perrigo USD 693.4M 41.8M Jun/2025
Pfizer USD 4.99B 2.4B Jun/2025
Supernus Pharmaceuticals USD 37.65M 21.88M Jun/2025
Teva Pharmaceutical Industries USD 2.07B 97M Jun/2025
Xeris Pharmaceuticals USD 11.9M 2.42M Jun/2025
Zoetis USD 682M 60M Jun/2025